All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
|
|
|
|
|
|
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
HLXA / Helix Acquisition Corp - Class A
|
|
|
|
|
|
|
|
CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
DMTK / DermTech, Inc.
|
|
|
|
|
|
|
|
BMEA / Biomea Fusion, Inc.
|
|
|
|
|
|
|
|
APYX / Apyx Medical Corporation
|
|
|
|
|
|
|
|
CVRX / CVRx, Inc.
|
|
|
|
|
|
|
|
TELA / TELA Bio, Inc.
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
NAUT / Nautilus Biotechnology, Inc.
|
|
|
|
|
|
|
|
TBIO / Telesis Bio, Inc.
|
|
|
|
|
|
|
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
RACB / Research Alliance Corp II - Class A
|
|
|
|
|
|
|
|
BLSA / BCLS Acquisition Corp - Class A
|
|
|
|
|
|
|
|
FVAM / 5:01 Acquisition Corp.
|
|
|
|
|
|
|
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
CCCC / C4 Therapeutics, Inc.
|
|
|
|
|
|
|
|
ATHA / Athira Pharma, Inc.
|
|
|
|
|
|
|
|
LUNG / Pulmonx Corporation
|
|
|
|
|
|
|
|
RXDX / Prometheus Biosciences Inc
|
|
|
|
|
|
|
|
NUVB / Nuvation Bio Inc.
|
|
|
|
|
|
|
|
AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
/ Cerevel Therapeutics Holdings, Inc. Warrant
|
|
|
|
|
|
|
|
PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
BIOR / Biora Therapeutics, Inc.
|
|
|
|
|
|
|
|
NSTG / NanoString Technologies, Inc.
|
|
|
|
|
|
|
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
DNAY / Codex DNA Inc
|
|
|
|
|
|
|
|
EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
PAYX / Paychex, Inc.
|
|
|
|
|
|
|
|
PSNL / Personalis, Inc.
|
|
|
|
|
|
|
|
SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CHAQ.U / Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of , and one
|
|
|
|
|
|
|
|
TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
INMD / InMode Ltd.
|
|
|
|
|
|
|
|
/ Nautilus Biotechnology Inc
|
|
|
|
|
|
|
|
SUMMIT HEALTHCRE ACQUISTN CO
/ UNIT 06/03/2026 (G8566R128) |
|
|
|
|
|
|
|
BCAB / BioAtla, Inc.
|
|
|
|
|
|
|
|
KYG5960S1241 / Medicus Sciences Acquisition Corp.
|
|
|
|
|
|
|
|
BLI / Berkeley Lights Inc
|
|
|
|
|
|
|
|
AZYO / Aziyo Biologics Inc - Class A
|
|
|
|
|
|
|
|
BDSX / Biodesix, Inc.
|
|
|
|
|
|
|
|
MRVI / Maravai LifeSciences Holdings, Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
NEO / NeoGenomics, Inc.
|
|
|
|
|
|
|
|
SEER / Seer, Inc.
|
|
|
|
|
|
|
|
CERN / Cerner Corp.
|
|
|
|
|
|
|
|
US92731L1145 / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
GMED / Globus Medical, Inc.
|
|
|
|
|
|
|
|
PROF / Profound Medical Corp.
|
|
|
|
|
|
|
|
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
|
|
|
|
|
|
|
|
KYG5960S1167 / Medicus Sciences Acquisition Corp. Unit
|
|
|
|
|
|
|
|
SPY / SPDR S&P 500 ETF
|
|
|
|
|
|
|
|
AFIB / Acutus Medical, Inc.
|
|
|
|
|
|
|
|
CERE / Cerevel Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
/ Conyers Park Acquisition Corp.
|
|
|
|
|
|
|
|
JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
OMIC / Singular Genomics Systems, Inc.
|
|
|
|
|
|
|
|
OYST / Oyster Point Pharma Inc
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
BOLT / Bolt Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
APVO / Aptevo Therapeutics Inc.
|
|
|
|
|
|
|
|
MDXG / MiMedx Group, Inc.
|
|
|
|
|
|
|
|
MASS / 908 Devices Inc.
|
|
|
|
|
|
|
|
ZY / Zymergen Inc
|
|
|
|
|
|
|
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
GHRS / GH Research PLC
|
|
|
|
|
|
|
|
BLU / Bellus Health Inc
|
|
|
|
|
|
|
|
MSAC / Medicus Sciences Acquisition Corp - Class A
|
|
|
|
|
|
|
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
VINC / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
AKYA / Akoya Biosciences, Inc.
|
|
|
|
|
|
|
|
OLK / Olink Holding AB (publ) - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ITOS / iTeos Therapeutics, Inc.
|
|
|
|
|
|
|
|
RCEL / AVITA Medical, Inc.
|
|
|
|
|
|
|
|
TWST / Twist Bioscience Corporation
|
|
|
|
|
|
|
|
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
AXNX / Axonics, Inc.
|
|
|
|
|
|
|
|
VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CUTRQ / Cutera, Inc.
|
|
|
|
|
|
|
|
CLSD / Clearside Biomedical, Inc.
|
|
|
|
|
|
|
|
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CSTL / Castle Biosciences, Inc.
|
|
|
|
|
|
|
|
MIRO / Miromatrix Medical Inc
|
|
|
|
|
|
|
|
TXG / 10x Genomics, Inc.
|
|
|
|
|
|
|
|
ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
LABP / Landos Biopharma, Inc.
|
|
|
|
|
|
|
|
ARYD / ARYA Sciences Acquisition Corp IV
|
|
|
|
|
|
|
|
PMVP / PMV Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
OM / Outset Medical, Inc.
|
|
|
|
|
|
|
|
RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|
MASI / Masimo Corporation
|
|
|
|
|
|
|
|
GH / Guardant Health, Inc.
|
|
|
|
|
|
|
|
MIST / Milestone Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
XGN / Exagen Inc.
|
|
|
|
|
|
|
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
RLMD / Relmada Therapeutics, Inc.
|
|
|
|
|
|
|
|
PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|